Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
Release Date:
Partner: Astellas
Review Process: Pfizer Internal
Education Oncology All
Promoting Understanding of COVID-19 and Vaccination and Improving Communication Skills for Healthcare Professionals
Release Date:
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Vaccines Japan
American Headache Society Quality Improvement Competitive Grant Program
Release Date:
Partner: American Headache Society
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
Boosting Oncology Opportunities for Support programs and Treatment, (BOOST), An Oncology Quality Boosting Program
Release Date:
Review Process: Expert Review Panel
Translation:(link)
Quality Improvement Oncology Netherlands
Investigator Sponsored Research for Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicit
Release Date:
Partner: National Comprehensive Cancer Network
Review Process: Expert Review Panel
Research Oncology USA
Improving Care for Patients with Recurrent/Metastatic (R/M) Cervical Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Title
Grant Type
Focus Area
Country
Application Due Date
Multidisciplinary Team Education in Duchenne Muscular Dystrophy (see RFP for specific geographic scope)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
2023/2024 Global NASH ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All
Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity via Meaningful Capacity Building in South East Asia
Release Date:
Partner: Conquer Cancer®, the ASCO Foundation
Review Process: Expert Review Panel
Quality Improvement Oncology Hong Kong, Indonesia, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Solomon Islands, Taiwan, Thailand, Vietnam
Alopecia Areata Education for Pediatric Dermatologists, Dermatologists, and Advanced Practice Providers
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Implementation of Revised USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and Opportunities
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Improving Care for Patients with Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
HRRm Testing in Metastatic Prostate Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Advancing Oncology Education for Healthcare Professionals
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Education Oncology Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Djibouti, Gabon, Guinea, Madagascar, Mali, Niger, Rwanda, Senegal, Seychelles, Togo
Providing Appropriate Medical Care for IBD Patients
Release Date:
Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Japan
Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology All
Addressing Gaps in Care for Patients with Multiple Myeloma (Europe)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Improving Breast Cancer (BC) Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa
Release Date:
Partner: Conquer Cancer®, the ASCO Foundation
Review Process: Expert Review Panel
Translation: French (link)
Translation: Portuguese (link)
Quality Improvement Oncology Congo, The Democratic Republic, Ethiopia, Ghana, Malawi, Mali, Mozambique, Rwanda, Senegal, Tanzania, United Republic of, Uganda, Zambia, Zimbabwe